These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37821382)

  • 1. m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia.
    Wu Z; Zuo X; Zhang W; Li Y; Gui R; Leng J; Shen H; Pan B; Fan L; Li J; Jin H
    Adv Sci (Weinh); 2023 Dec; 10(34):e2304895. PubMed ID: 37821382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
    Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
    J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway.
    Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ
    Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA.
    Zhou Y; Xue X; Luo J; Li P; Xiao Z; Zhang W; Zhou J; Li P; Zhao J; Ge H; Tian Z; Zhao X
    Cancer Sci; 2023 Sep; 114(9):3608-3622. PubMed ID: 37417427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
    Wu Y; Jin M; Fernandez M; Hart KL; Liao A; Ge X; Fernandes SM; McDonald T; Chen Z; Röth D; Ghoda LY; Marcucci G; Kalkum M; Pillai RK; Danilov AV; Li JJ; Chen J; Brown JR; Rosen ST; Siddiqi T; Wang L
    Blood Cancer Discov; 2023 May; 4(3):228-245. PubMed ID: 37067905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
    Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
    Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells.
    Gu Z; Yang Y; Ma Q; Wang H; Zhao S; Qi Y; Li Y
    Respir Res; 2022 Dec; 23(1):362. PubMed ID: 36536402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner.
    Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P
    Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.
    Pan B; Xu Z; Du K; Gao R; Zhang J; Yin H; Shen H; Liang J; Li Y; Wang L; Li J; Xu W; Wu J
    Ann Hematol; 2024 Apr; 103(4):1241-1254. PubMed ID: 38150112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
    Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
    Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.
    Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis.
    Wu W; Wu Z; Xia Y; Qin S; Li Y; Wu J; Liang J; Wang L; Zhu H; Fan L; Fu J; Xu W; Jin H; Li J
    Aging (Albany NY); 2019 Jun; 11(11):3561-3573. PubMed ID: 31152142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value and multiomic features of m6A-related risk signature in lung adenocarcinoma.
    Wang X; Yu Q; Yu H; Wang Y; Sun L; Yu L; Cui H; Yang H
    Am J Transl Res; 2022; 14(8):5379-5393. PubMed ID: 36105012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.
    Xia L; Wu L; Bao J; Li Q; Chen X; Xia H; Xia R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):385-390. PubMed ID: 29902450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
    Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
    Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.